Milestone for BioNTech
325 Million USD for further development of its cancer immunotherapy. Learn more at: https://biontech.de/2019/07/09/biontech-raises-usd-325-million-in-an-upsized-series-b-financing-to-further-advance-individualized-immuno-oncology-pipeline/